The health insurer said it plans to sell its Medicare prescription drug business in a key step toward completing its $67.5 billion merger.

While the DOJ’s antitrust division says the merger doesn’t eliminate competition, industry experts are doubtful the deal will bring down costs or improve quality.

While the DOJ’s antitrust division says the merger doesn’t eliminate competition, industry experts are doubtful the deal will bring down costs or improve quality.

The deal is seen closing by the end of the year.

The recent uptick in mergers is a response to the demand for better technology and increased efficiency.

The benefit tech provider is building a consortium to offer its employee benefits software, services.

The benefit tech provider is building a consortium to offer its employee benefits software, services.

The pharmacy company has dodged one hurdle, as antitrust enforcers don’t see competitive problems stemming from uniting companies that operate at different levels of a supply chain.

Deals dipped slightly compared to 2018’s first quarter; however it is not indicative of overall trend for mergers and acquisitions in North America, according OPTIS Partners’ recent M&A Database report.

The newly acquired health marketing agency uses data and analytics to help clients navigate payer behavior and the reimbursement environment.